ELIZABETH STRAND: Open Payments
NPI 1245483049 · NEWTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,487 in 21 payments from 6 companies in 2025. Trend: 2023 $53 · 2024 $104 · 2025 $1,487
Long term medical supply or device loan: $1,097Food & beverage: $391
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $1,296 |
| Gilead Sciences, Inc. | 1 | $65 |
| Genentech USA, Inc. | 2 | $50 |
| Exelixis Inc. | 1 | $34 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Lilly USA, LLC | 1 | $20 |
Products named: KISQALI, Trodelvy, Itovebi, CABOMETYX, KEYTRUDA, VERZENIO.
Industry payments across MA — which companies pay providers there.
